Table 1.
Demographics and disease characteristics of primary Sjögren’s syndrome patients without and with non-Hodgkin lymphoma at visit 1 and visit 2
| pSS patients without NHL | pSS patients with NHL | |||
|---|---|---|---|---|
| Visit 1 | Visit 2 | Visit 1 | Visit 2 | |
| No. of pSS patients | 273 | 200 | 38 | 8 |
| Female gender (%) | 91 | 90 | 95 | 81 |
| Age, years median (Q1, Q3) | 64 (54, 70) | 65 (55, 71) | 59 (42.8, 68.3) | 48.5 (44, 73) |
| pSS duration from AECG diagnosis, years median (Q1, Q3) | 4 (1, 9) | 8 (5, 15) | 7.5 (2, 14.3) | 9.5 (5.3, 17) |
| pSS duration from symptoms onset, years median (Q1, Q3) | 10 (5, 16) | 15 (8, 21.8) | 15.5 (7, 27.5) | 15.5 (10, 30.8) |
| ESSDAI score median (Q1, Q3) | 4 (1, 8) | 2 (0, 7) | 6 (2, 13) | 1 (0, 13) |
| ESSPRI score median (Q1, Q3) | 5.6 (4, 7) | 6 (5, 7.7) | 5.6 (4, 7.6) | 6 (3.6, 7.8) |
AECG American-European consensus classification criteria, ESSDAI EULAR Sjögren’s syndrome disease activity index, ESSPRI EULAR Sjögren’s syndrome patient reported index